Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Prasugrel in Diabetic Patients
NCT03027934Phase 4Withdrawn
- Sponsor
- CirQuest Labs
- Start
- Aug 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ticagrelor in diabetes mellitus (DM), sponsored by CirQuest Labs. Planned start Aug 2017; status: withdrawn.
02
Drugs
ticagrelor
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT03027934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03027934.